ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Muscle strength"

  • Abstract Number: 2480 • ACR Convergence 2025

    Respiratory Muscle Weakness in a Systemic Sclerosis Cohort

    Fabian Mendoza1, Wendy Perdomo2, Timothy Wilson1 and Sergio Jimenez1, 1Thomas Jefferson University, Philadelphia, PA, 2Thomas Jefferson University Hospital, Philadelphia, PA

    Background/Purpose: Systemic sclerosis (SSc) is a complex autoimmune disorder marked by vascular damage, immune dysregulation, and fibrosis. Lung involvement, particularly interstitial lung disease (ILD), carries…
  • Abstract Number: 2123 • ACR Convergence 2025

    Sclerostin in Aging Bone and Muscle: A Comparative Study of Osteoporosis, Sarcopenia, and Osteosarcopenia

    Mohamed Tharwat Hegazy1, Fatma Fayed1, Shirihan Mahgoub1, Yasmin El Ebrashy2 and Maha Hossam Al-Din Ibrahim1, 1Faculty of Medicine, Cairo University, Cairo, Egypt, 2National institute of Diabetes and Endocrinology, Cairo, Egypt

    Background/Purpose: Osteoporosis, sarcopenia, and frailty are the 3 determinants of aging. A novel syndrome of combined osteosarcopenia has negative health outcomes among geriatric populations. In…
  • Abstract Number: 2070 • ACR Convergence 2025

    Characterization of Hospitalization, Patient Demographics and Impact of Idiopathic Inflammatory Myopathies on Hospitalization Outcomes in Adult Fracture Patients: A National Inpatient Sample Analysis.

    Pranathi Bandarupalli1, Vineeth Potluri2, Amr Alemairy2, Harsharn Grewal2 and Shudipan Chakraborthy2, 1Mercy St Vincent Medical Center, Toledo, OH, 2Mercy Health St. Vincent Medical Center, Toledo, OH

    Background/Purpose: Idiopathic Inflammatory Myopathies (IIM), including polymyositis and dermatomyositis, are rare systemic autoimmune disorders characterized by chronic muscle inflammation and progressive muscle weakness. Patients with…
  • Abstract Number: 2056 • ACR Convergence 2025

    Systematic Review: Nutritional Interventions in Muscle Diseases

    Deepanjali Vedantam1, Taanya Talreja2, Pranathi Bandarupalli3, Sheryl Salis4, Debra Lupeika5, Ashley Maclean6, Karen Cheng7, Teerin Liewluck8, Lakshmi Nagendra9 and Latika Gupta10, 1Shasta Regional Medical Centre, Redding, CA, 2KEM Hospital, Mumbai, Maharashtra, India, 3Mercy St Vincent Medical Center, Toledo, OH, 4Nurture Health Solutions, Mumbai, Maharashtra, India, 5Department of Family Medicine, UC Davis, Redding, 6Vacaville Ranch Post Acute, Redding, 7., Basel, Switzerland, 8Division of Neuromuscular Medicine, Department of Neurology, Mayo clinic-Rochester, Rochester, 9Department of Endocrinology, JSS Academy of Higher Education and Research, Mysore, Karnataka, India, 10School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham; Royal Wolverhampton NHS Trust; Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester; Francis Crick Institute, London, Birmingham, UK, United Kingdom

    Background/Purpose: Medical nutrition therapy significantly impacts cardiovascular risk and overall health, but effects on muscle diseases remain unclear. This systematic review evaluates nutritional interventions' safety…
  • Abstract Number: 1211 • ACR Convergence 2025

    Plasma Levels of miR-133a-3p and miR-1-3p as Potential Biomarkers of Muscle Involvement and Initial Treatment Response in Myositis

    Kristina Svobodová1, Sabína Oreská1, Lucia Vernerová2, Dana Dlouhá3, Hana Wunsch2, Karel Pavelka2, Jiri Vencovsky4, Ladislav Šenolt5, Michal Vrablik6, Jaroslav Alois Hubáček3 and Michal Tomcik2, 1Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 3Experimental Medicine Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 4Institute of Rheumatology, Praha 8, Czech Republic, 5Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 63rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) involve muscle inflammation. MicroRNAs (miRNAs), such as miR-133a-3p and miR-1-3p, play a key role in gene regulation and muscle repair.…
  • Abstract Number: 1209 • ACR Convergence 2025

    Beyond Muscle Strength: Functional Performance Measures Enhance Assessment of Disease Activity in Juvenile Dermatomyositis

    Jia Shi1, Alexander Carpenter2, Christopher Wong2, Qian Wang3, Christian Lood4 and Susan Shenoi5, 1University of Washington, Seattle, WA, 2Division of Rheumatology, Seattle Children's Hospital and Research Center, Seattle, 3Peking Union Medical College Hospital, Beijing, Beijing, China (People's Republic), 4University of Washington, Division of Rheumatology, Seattle, 5Seattle Children's Hospital and Research Center, Mercer Island, WA

    Background/Purpose: To evaluate the measurement properties of functional performance measures (FPMs)—broad jump (BJ) and 10-meter run (10MR)—for assessing muscle function and disease activity in children…
  • Abstract Number: 1207 • ACR Convergence 2025

    Cutaneous and Muscular Disease Trajectories in Adult Patients with Dermatomyositis

    Jesus Valencia1, Will Kelly1, Sean Tackett2, Amanda Finney1, Jemima Albayda1, Julie Paik3, Lisa Christopher-Stine1 and Chris Mecoli4, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University, Baltimore, 3Johns Hopkins Rheumatology, Baltimore, MD, 4Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Dermatomyositis (DM) is a rare autoimmune disease characterized by cutaneous manifestations and proximal muscle inflammation.1,2 Notably, the clinical course of muscular and cutaneous disease…
  • Abstract Number: PP06 • ACR Convergence 2025

    Co-Creation of Exercise Videos by Patients and Professionals to Support Patient Empowerment

    Noriko Okochi, Eiji Oishi, Yoshifumi Hitoe, Hitomi Koshi, Hajime Kono

    Background/Purpose: Rheumatic and musculoskeletal diseases (RMDs) cause chronic pain, joint deformities, and reduced mobility, significantly limiting patients’ daily activities and social participation. Physical inactivity can…
  • Abstract Number: 2692 • ACR Convergence 2025

    Individualized Strength, Mobility and Aerobic Rehabilitation Training in axial Spondyloarthritis (iSMART in axSpA)

    Sophie De Mits1, Tine Willems2, Lieven Danneels2, Patrick Calders2, Gaëlle Varkas3, Filip Van den Bosch4, Dirk Elewaut5 and Philippe Carron6, 1Ghent University Hospital, Gent, Belgium, 2Ghent University, Gent, Belgium, 3Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 4Department of Internal Medicine and Pediatrics, Ghent University and VIB Center for Inflammation Research, Ghent, Belgium, 5VIB Center for Inflammation Research, and Ghent University Hospital, Department of Rheumatology, Ghent, Belgium, 6Ghent University and VIB Center for Inflammation Research, Ghent, Belgium

    Background/Purpose: AxSpA primarily affects the sacroiliac joints and spine, reducing trunk strength, mobility, and cardiorespiratory fitness. While exercise is a key treatment, few studies have…
  • Abstract Number: 2670 • ACR Convergence 2025

    Real-World Experience of Anifrolumab in 24 Patients with Refractory Dermatomyositis: A Multicenter Retrospective Study.

    Miriam Retuerto Guerrero1, Clara Moriano2, Ana Pareja-Martínez3, Natalia Molina-Esteban4, Jose Puig-Buendia5, Concepción Postigo-Llorente5, Ana Lopez-Ceron Cofiño6, Julia Martínez Barrio7, Paola Vidal-Montal8, Elena Sendagorta Cudos9, GUILLERMO GONZALEZ ARRIBAS10, Jaime Calvo11, Juan Ramon De Dios12, Juan María Blanco-Madrigal13, Paloma Vela Casasempere14, Javier Bachiller15, Concepción Fito-Manteca16, Carmen Ordas calvo17, Luisa Martos Cabrera18, Alejandro Sanchez Herrero19, Luis Ortega-Valin20 and Elvira Diez Alvarez21, 1Complejo Asistencial Universitario de León, Leon, Castilla y Leon, Spain, 2Hospital León, LEON, Castilla y Leon, Spain, 3Rheumatology. Hospital Universitario Infanta Leonor, Madrid, Madrid, Spain, 4Rheumatology. Hospital Universitario 12 de octubre, Madrid, Madrid, Spain, 5Dermatology. Hospital universitario 12 de octubre, Madrid, Madrid, Spain, 6Rheumatology. Complejo Asistencial Universitario de Soria, Soria, Castilla y Leon, Spain, 7Department of Rheumatology, Hospital Gregorio Marañón, Madrid, Spain, Madrid, Madrid, Spain, 8Rheumatology. Hospital Universitari de Bellvitge, Barcelona, Catalonia, Spain, 9Dermatology. Hospital universitario La Paz, Madrid, Madrid, Spain, 10Facultativo especialista, PALMA DE MALLORCA, Galicia, Spain, 11Department of Rheumatology, Hospital Universitario Araba, School of Medicne, Universidad del País Vasco, BIOARABA Health Research Institute, Vitoria, Spain, Vitoria, Pais Vasco, Spain, 12Department of Rheumatology. Hospital Universitario Araba. Instituto de Investigación Sanitaria BIORABA., Vitoria, Pais Vasco, Spain, 13Rheumatology. Hospital Universitario Araba., Vitoria, Pais Vasco, Spain, 14Hospital General Universitario Alicante, Alicante, Comunidad Valenciana, Spain, 15Hospital Ramon y Cajal, Madrid, Madrid, Spain, 16Rheumatology. Hospital Universitario de Navarra., Pamplona, Navarra, Spain, 17Rheumatology. Hospital Universitario de Cabueñes., Gijon, Asturias, Spain, 18Dermatology. Hospital Universitario de La Princesa, Madrid, Madrid, Spain, 19Dermatology. Complejo Asistencial Universitario de Leon, Leon, Castilla y Leon, Spain, 20Pharmacy. Complejo Asistencial Universitario de Leon, Leon, Castilla y Leon, Spain, 21Rheumatology. Complejo Asistencial Universitario de Leon, Leon, Castilla y Leon, Spain

    Background/Purpose: Dermatomyositis (DM) is a systemic autoimmune disease marked by muscle weakness and characteristic cutaneous manifestations. Dysregulation of the Type I interferon (IFN-I) pathway plays…
  • Abstract Number: 0175 • ACR Convergence 2024

    Do Knee Strength and Pain Relate to Developing Stair Climbing Difficulty for Knee Osteoarthritis?

    Jason Jakiela1, Yvonne Golightly2, Sydney Liles3, Judy Foxworth4 and Daniel White5, 1Winston-Salem State University, Winston-Salem, NC, 2University of Nebraska Medical Center, Omaha, NE, 3University of Delaware, Elkton, MD, 4Winston-Salem State University, Elon, NC, 5University of Delaware, Newark, DE

    Background/Purpose: Knee osteoarthritis (OA) is a leading cause of functional limitation in older adults, and stair climbing difficulty is often the first-reported limitation. Previous work…
  • Abstract Number: 0489 • ACR Convergence 2024

    Use of Chair Sit-to-Stand as a Pragmatic Alternative to Assess Frailty in Rheumatoid Arthritis

    Hannah Brubeck1, Kylie Riggles2, Riley Bass3, Elizabeth Wahl4, James Andrews5, Namrata Singh6, ariela orkaby7, Joshua Baker8, Patti Katz9, Dolores Shoback10, Jose Garcia11 and Katherine Wysham12, 1VA Puget Sound Health Care System, Seattle, WA, 2VA Puget Sound Health Care System, Bellevue, WA, 3VA Puget Sound Health Care System, Seattle, 4VA Puget Sound Healthcare System, Seattle, WA, 5University of Alabama at Birmingham, Birmingham, AL, 6University of Washington, Bellevue, WA, 7New England VA Geriatric Research Education and Clinical Center/Boston VA/Division of Aging, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 8University of Pennsylvania, Philadelphia, PA, 9UCSF, San Rafael, CA, 10San Francisco VA/University of California, San Francisco, San Francisco, CA, 11VA Puget Sound Health Care System/University of Washington, Seattle, WA, 12VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA

    Background/Purpose: Frailty occurs earlier in people with rheumatoid arthritis (RA) than in the general population and is associated with poor health outcomes1, making it important…
  • Abstract Number: 0560 • ACR Convergence 2024

    Association Between a Self-Report Screening Tool for Sarcopenia (SARC-F) and Disease Activity, Muscle Strength and Muscle Power Measures, Patient-Reported Outcomes and Body Composition in Patients with Spondyloarthritides

    Iuliia Kononenko1, Marius Bedei2, Bjoern Buehring3, Xenofon Baraliakos4 and Uta Kiltz5, 1Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Germany, Bochum, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Germany, Herne, Germany, 3Bergisches Rheuma-Zentrum, Wuppertal, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Ruhr-University, D-44649 Herne, Germany

    Background/Purpose: The SARC-F is a self-report screening tool for sarcopenia (Sar) used to identify individuals at risk for poor functional outcomes [1]. The aim of this study was…
  • Abstract Number: 1182 • ACR Convergence 2024

    Assessing Male Pelvic Floor Contractions Using a Novel External Pressure Device and Ultrasound

    Benedetto Giardulli1, Mirko Job1, Filippo Recenti1, Gaia Leuzzi1, Alessandro Muda2, Ottavia Buccarella1 and Marco Testa1, 1University of Genova, Savona, Italy, 2Lavagna Hospital - Radiology Dept., Genova, Italy

    Background/Purpose: Men with rheumatic and musculoskeletal diseases (RMD) often experience sexual dysfunctions such as pelvic floor pain and erectile dysfunctions, which affect their sexual well-being.…
  • Abstract Number: 2125 • ACR Convergence 2024

    Strengthening Fracture Risk Prediction in Rheumatoid Arthritis: Integrating a Self-report Sarcopenia Screening Tool (SARC-F) and Fracture Risk Assessment Tool (FRAX) Scores

    Ana Rodriguez-Flores1, Ana Cecilia Bardan-Inchaustegui2, Mara Ponce2, Galilea Rodriguez3, Anahí Carrazco Chapa4, Valeria Monserrat De Hoyos-Perez5, Gilberto J Cervantes Charles5, Alma Damian Peñaloza5, Cinthia Maribel Cortez Lopez5, CASSANDRA SKINNER TAYLOR6, Roberto Negrete Lopez5, Jesus Cardenas-de la Garza2 and Dionicio Galarza-Delgado7, 1Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 3Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, UANL, Rheumatology, Monterrey, Mexico, Monterrey, Mexico, 5Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 6HOSPITAL UNIVERSITARIO DR JOSE ELEUTERIO GONZALEZ, MONTERREY, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of fractures due to factors such as chronic inflammation, use of glucocorticoids, and reduced muscle mass.…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology